Skip to main content
  • Saved

made a Post

Risk of SARS-CoV2-related mortality in non-small cell lung cancer patients treated with first-line immunotherapy alone or in combination with chemotherapy - PubMed

Risk of SARS-CoV2-related mortality in non-small cell lung cancer patients treated with first-line immunotherapy alone or in combination with chemotherapy - PubMed

Source :

https://pubmed.ncbi.nlm.nih.gov/34409906/

doi: 10.1080/07357907.2021.1970761. Online ahead of print. 1 Department of Oncology, Queen Alexandra University Hospital, Portsmouth Hospitals NHS Trust, United Kingdom. 2 Department of Experimental Oncology, Mediterranean Institute of Oncology (IOM), Catania, Italy. 3 Oncology Department, Geneva University Hospital, Geneva, Switzerland. doi: 10.1080/07357907.2021.1970761. Online ahead of print.